In-silico techniques to inform and improve the personalized prescription of shoe insoles

Front Bioeng Biotechnol. 2024 Feb 23:12:1351403. doi: 10.3389/fbioe.2024.1351403. eCollection 2024.

Abstract

Background: Corrective shoe insoles are prescribed for a range of foot deformities and are typically designed based on a subjective assessment limiting personalization and potentially leading to sub optimal treatment outcomes. The incorporation of in silico techniques in the design and customization of insoles may improve personalized correction and hence insole efficiency. Methods: We developed an in silico workflow for insole design and customization using a combination of measured motion capture, inverse musculoskeletal modelling as well as forward simulation approaches to predict the kinematic response to specific insole designs. The developed workflow was tested on twenty-seven participants containing a combination of healthy participants (7) and patients with flatfoot deformity (20). Results: Average error between measured and simulated kinematics were 4.7 ± 3.1, 4.5 ± 3.1, 2.3 ± 2.3, and 2.3 ± 2.7° for the chopart obliquity, chopart anterior-posterior axis, tarsometatarsal first ray, and tarsometatarsal fifth ray joints respectively. Discussion: The developed workflow offers distinct advantages to previous modeling workflows such as speed of use, use of more accessible data, use of only open-source software, and is highly automated. It provides a solid basis for future work on improving predictive accuracy by adapting the currently implemented insole model and incorporating additional data such as plantar pressure.

Keywords: ankle; design methodology; in-silico; insole ankle foot orthotic; musculoskeletal.

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was financially by the In-Silico World (ISW) project. ISW project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme, under Grant Agreement n. 101016503.